Clinical Trials Directory

Trials / Unknown

UnknownNCT01490541

The Predictive Scores for Gastric Cancer in Gastric Intestinal Metaplasia (GIM) Patient: a Recommendation for Thai Population

Status
Unknown
Phase
Study type
Observational
Enrollment
280 (estimated)
Sponsor
King Chulalongkorn Memorial Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The predictive scores for gastric cancer in gastric intestinal metaplasia(GIM) patient: a recommendation for Thai population. Objective: To evaluate major risk factors for gastric cancer in gastric intestinal metaplasia(GIM) patient in order to propose the appropriate recommendation for Thai people. Research Design: Single center, retrospective-cohort study.

Detailed description

Study population and Sample size at Faculty of Medicine, Chulalongkorn University The patients who were diagnosed gastric intestinal metaplasia from 1997 to 2012 and then follow up for 5 years. Estimate sample size =280 * Investigational product, dosage \& route of administration * Questionnaire for explore the risk factors * EGD with biopsy * Blood sampling for gastro panel * Duration of participation * 5 years or until diagnose gastric cancer Statistical method: Unconditional-binary-logistic regression

Conditions

Timeline

Start date
2011-10-01
Primary completion
2012-12-01
Completion
2017-10-01
First posted
2011-12-13
Last updated
2012-06-25

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01490541. Inclusion in this directory is not an endorsement.